#Sars

Fatima Tokhmafshan (she/elle) 🇨🇦🏳️‍🌈

DeNovo_Fatima

Cher @cdube_sante @sante_qc voici un cadeau de Noël pour vous:quelques-uns des nombreux articles scientifiques sur la #transmissionaérosole L'un des 1ers articles, publié dans le journal ‘Aerosol Science & Technology’ en

Atomsk's Sanakan

AtomsksSanakan

1/PPeter C Gøtzsche (@PGtzsche1) wrote the article belowHe argues that COVID-19 isn't very lethal, + then draws some political conclusions.The article is poor."Is the infection fatality rate for COVID-19 worse

U z a i r (عزير)

UzairEssack

How to start your own business:1. Go online to the website of CIPC and register a new company for R175. Registration is R125 and the name is R50.2. Go to

A Marm Kilpatrick

DiseaseEcology

Current evidence on immunity for #COVID19.My *non-expert* overview(replying to comment by @taaltree & would love help/comments from actual immunity expert: @florian_krammer or others)Threadhttps://twitter.com/taaltree/status/12832338636

Christina Pagel

chrischirp

THREAD: Takeaway messages from our @IndependentSage weekly briefing today. (TLDR: cases going up but slowly, act now, ditch central test and trace system, go local and drive cases down for

Alina Chan

Ayjchan

Estimated 76% Manaus and 29% São Paulo population infected by covid by October."These results confirm that, when poorly controlled, COVID-19 can infect a high fraction of the population causing high

Michael Mina

michaelmina_lab

ImportantThis virus is not happening in a vacuum where no information existed previouslyOn Immunity, On testing, On serology, On transmission, On masks, On treatments...We must stop this narrative that we

Muge Cevik

mugecevik

2- There's a delicate balance between preventing infections and increasing lockdown fatigue. People do not have unlimited energy, so we should ask them to be vigilant where it matters most,

David Fisman

DFisman

Vaccine prioritization in phase II in Ontario: the province has put out a framework, which seems not unreasonable (https://toronto.ctvnews.ca/ontario-releases-list-of-those-eligible-for-covid-19-vaccine-under-phase-2-1.5264702?cache=ngyhfzx

Alina Chan

Ayjchan

@washingtonpost Opinion article by their editorial board."there are troubling questions in China that must be examined, including whether the coronavirus was inadvertently spread in an accident or spill from the

Jan B. Hommel

hommel_b

https://www.aier.org/article/why-did-the-u-s-copy-china-on-virus-control/Uitermate kritisch, uitermate goed onderbouwd, uitermate goed geïnformeerd. Een eiland van kennis en wetenschap, te midden van een zee van domheid en onkunde van de M

Andrew Junkin, MD

Dr_Junkin_MD

Seeing as the COVID-19 #vaccine will be an extremely limited resource initially, should we consider testing each potential recipient for SARS-CoV-2 IgG positivity before administering the vaccine in distribution Phase

papa wemba!

lexyy4real

I just read this beautiful thread and I'll like to give a robust reply on it....It is guaranteed in the constitution of the federal republic of Nigeria the right to

Dr. Rob Davidson #WearAMask

DrRobDavidson

Comparing #MAGA Rallies to #BlackLivesMatter protests in terms of #COVID19 risk is the new false equivalency. As a doctor I see unique public health risk with a #TrumpRally, which

Pete Lincoln

petelincoln48

1/Reading the FDA report of Pfizer Vax EUA. Some interesting pointshttps://www.fda.gov/media/144245/download 2/It says “In the event an EUA is issued for this product, it would still be considered unapproved and

🐴🐵

Subhashitani1

Antivirals approved other viruses being tested against SARS-CoV-2 in randomized controlled trials (RCT). Such drug repurposing ― testing drugs approved for other viruses ― is the logical shortcut for drug

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.